JP2020502183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502183A5 JP2020502183A5 JP2019532941A JP2019532941A JP2020502183A5 JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5 JP 2019532941 A JP2019532941 A JP 2019532941A JP 2019532941 A JP2019532941 A JP 2019532941A JP 2020502183 A5 JP2020502183 A5 JP 2020502183A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- amino acid
- composition
- acid entity
- tripeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662436073P | 2016-12-19 | 2016-12-19 | |
| US62/436,073 | 2016-12-19 | ||
| US201762443205P | 2017-01-06 | 2017-01-06 | |
| US62/443,205 | 2017-01-06 | ||
| US201762491776P | 2017-04-28 | 2017-04-28 | |
| US62/491,776 | 2017-04-28 | ||
| US201762545358P | 2017-08-14 | 2017-08-14 | |
| US62/545,358 | 2017-08-14 | ||
| US201762576321P | 2017-10-24 | 2017-10-24 | |
| US62/576,321 | 2017-10-24 | ||
| PCT/US2017/067368 WO2018118957A1 (en) | 2016-12-19 | 2017-12-19 | Amino acid compositions and methods for the treatment of muscle diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502183A JP2020502183A (ja) | 2020-01-23 |
| JP2020502183A5 true JP2020502183A5 (enExample) | 2021-02-12 |
Family
ID=61025047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019532941A Pending JP2020502183A (ja) | 2016-12-19 | 2017-12-19 | アミノ酸組成物ならびに筋肉疾患および障害の治療方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20180207119A1 (enExample) |
| EP (1) | EP3554493A1 (enExample) |
| JP (1) | JP2020502183A (enExample) |
| KR (1) | KR20190099243A (enExample) |
| CN (1) | CN110267655A (enExample) |
| AU (1) | AU2017379825A1 (enExample) |
| BR (1) | BR112019012476A2 (enExample) |
| CA (1) | CA3046558A1 (enExample) |
| CL (1) | CL2019001685A1 (enExample) |
| CO (1) | CO2019006292A2 (enExample) |
| CU (1) | CU20190057A7 (enExample) |
| EC (1) | ECSP19043725A (enExample) |
| IL (1) | IL267210A (enExample) |
| JO (1) | JOP20190147A1 (enExample) |
| MA (1) | MA50763A (enExample) |
| MX (1) | MX2019007352A (enExample) |
| PE (1) | PE20191206A1 (enExample) |
| PH (1) | PH12019501339A1 (enExample) |
| TW (1) | TWI780096B (enExample) |
| WO (1) | WO2018118957A1 (enExample) |
| ZA (1) | ZA201903581B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| US11617731B2 (en) | 2017-04-28 | 2023-04-04 | Axcella Health, Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
| WO2019036471A1 (en) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE |
| EP3684350A1 (en) * | 2017-08-14 | 2020-07-29 | Axcella Health Inc. | Amino acids compositions for the treatment of neuronal injury |
| EP3810276A1 (en) * | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the reduction or treatment of inflammation |
| CA3099762A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
| MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| EP3856167A1 (en) * | 2018-09-27 | 2021-08-04 | Société des Produits Nestlé S.A. | Use of histidine, glycine and other aminoacids for preventing insulin resistance and/or diabetes |
| CN113924089A (zh) * | 2019-06-07 | 2022-01-11 | 雀巢产品有限公司 | 使用一种或多种自噬诱发氨基酸来增强一种或多种合成代谢氨基酸的肌肉骨骼效应的组合物和方法 |
| US20220184015A1 (en) * | 2019-06-20 | 2022-06-16 | Societe Des Produits Nestle S.A. | Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health |
| IT201900010437A1 (it) | 2019-06-28 | 2020-12-28 | Dompe Farm Spa | Composizione per il trattamento del deperimento muscolare |
| KR102456270B1 (ko) * | 2019-09-24 | 2022-10-19 | 마이오텍사이언스 주식회사 | 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| KR102338447B1 (ko) * | 2019-09-24 | 2021-12-14 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| WO2021060880A1 (ko) * | 2019-09-24 | 2021-04-01 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
| CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
| US20230089723A1 (en) * | 2020-03-06 | 2023-03-23 | Axcella Health Inc. | Amino acid compositions and methods for muscle and myotube modulation |
| KR102802853B1 (ko) * | 2021-02-26 | 2025-05-07 | 이엑스헬스케어 주식회사 | 피부 유래 엑소좀을 통해 근손실 억제 또는 근생성 촉진 효과를 나타내는 조성물 |
| CN113288890B (zh) * | 2021-06-21 | 2022-02-22 | 南方医科大学南方医院 | N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用 |
| WO2024026307A1 (en) | 2022-07-25 | 2024-02-01 | Axcella Health Inc. | Biomarker for long covid and fatigue |
| WO2024030909A1 (en) | 2022-08-01 | 2024-02-08 | Axcella Health Inc. | Biomarkers of amino acid composition treatment response in long covid |
| WO2025167857A1 (zh) * | 2024-02-06 | 2025-08-14 | 南京纽邦生物科技有限公司 | 用于增强或改善肌肉功能和/或提高运动表现和/或预防或缓解疲劳的方法和组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001257917A1 (en) * | 2000-02-01 | 2001-08-14 | Muscletech Research And Development Inc. | Alpha lipoic acid based food supplement to increase lean muscle mass and strength |
| US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| US20060002913A1 (en) * | 2004-06-22 | 2006-01-05 | Gehlsen Kurt R | Use of histamine and related compounds to treat disorders affecting muscle function |
| WO2006105112A2 (en) * | 2005-03-29 | 2006-10-05 | Ajinomoto Co., Inc. | Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| JP2007023921A (ja) * | 2005-07-19 | 2007-02-01 | Toyota Motor Corp | 内燃機関の制御装置 |
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| CN100518815C (zh) * | 2007-02-15 | 2009-07-29 | 北京苏里曼医药科技有限公司 | 一种氨基酸组合物 |
| MX2014001996A (es) * | 2011-08-19 | 2014-08-29 | Musclepharm Corp | Composiciones y metodos para usarse en promover masa corporal magra. |
| EP3060231A1 (en) * | 2013-10-23 | 2016-08-31 | The Whitehead Institute for Biomedical Research | Mtorc1 modulation by amino acids and uses thereof |
-
2017
- 2017-06-16 JO JOP/2019/0147A patent/JOP20190147A1/ar unknown
- 2017-12-19 KR KR1020197020658A patent/KR20190099243A/ko not_active Ceased
- 2017-12-19 WO PCT/US2017/067368 patent/WO2018118957A1/en not_active Ceased
- 2017-12-19 CN CN201780078594.XA patent/CN110267655A/zh active Pending
- 2017-12-19 CA CA3046558A patent/CA3046558A1/en active Pending
- 2017-12-19 BR BR112019012476A patent/BR112019012476A2/pt not_active IP Right Cessation
- 2017-12-19 MA MA050763A patent/MA50763A/fr unknown
- 2017-12-19 EP EP17835529.3A patent/EP3554493A1/en not_active Withdrawn
- 2017-12-19 PE PE2019001282A patent/PE20191206A1/es unknown
- 2017-12-19 JP JP2019532941A patent/JP2020502183A/ja active Pending
- 2017-12-19 US US15/847,343 patent/US20180207119A1/en not_active Abandoned
- 2017-12-19 CU CU2019000057A patent/CU20190057A7/es unknown
- 2017-12-19 TW TW106144666A patent/TWI780096B/zh not_active IP Right Cessation
- 2017-12-19 MX MX2019007352A patent/MX2019007352A/es unknown
- 2017-12-19 AU AU2017379825A patent/AU2017379825A1/en not_active Abandoned
- 2017-12-29 US US15/858,605 patent/US20180169047A1/en not_active Abandoned
- 2017-12-29 US US15/858,475 patent/US20180169046A1/en not_active Abandoned
-
2019
- 2019-06-04 ZA ZA2019/03581A patent/ZA201903581B/en unknown
- 2019-06-10 IL IL267210A patent/IL267210A/en unknown
- 2019-06-13 PH PH12019501339A patent/PH12019501339A1/en unknown
- 2019-06-17 CO CONC2019/0006292A patent/CO2019006292A2/es unknown
- 2019-06-19 EC ECSENADI201943725A patent/ECSP19043725A/es unknown
- 2019-06-19 CL CL2019001685A patent/CL2019001685A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502183A5 (enExample) | ||
| TWI780096B (zh) | 胺基酸組合物及肌肉疾病與病症之治療方法 | |
| ES2221385T3 (es) | Preparaciones de gabapentina y pregabalina estabilizadas con aminoacidos y procedimiento para prepararlas. | |
| US7645796B2 (en) | Amino acid composition promoting collagen synthesis | |
| TWI775921B (zh) | 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法 | |
| WO2005017094A3 (en) | N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency | |
| CN108721596B (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| JP2013516464A5 (enExample) | ||
| RU2008126294A (ru) | Способы лечения потери мышечной массы | |
| JP2006522821A5 (enExample) | ||
| JPS61247354A (ja) | 栄養素組成物 | |
| WO2021178860A1 (en) | Amino acid compositions and methods for muscle and myotube modulation | |
| JPWO2019036471A5 (enExample) | ||
| Johannessen et al. | The acute effect of valproate on cerebral energy metabolism in mice | |
| ATE541568T1 (de) | Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten | |
| JPH0116809B2 (enExample) | ||
| JP2006524182A5 (enExample) | ||
| JPWO2000043035A1 (ja) | アミノ酸含有アルブミン製剤 | |
| JPWO2019246225A5 (enExample) | ||
| NZ723300A (en) | Compositions for the prevention and/or treatment of pathologies associated with alpha-glucosidase | |
| RU2008123806A (ru) | Лекарственное средство, применяющееся при поражениях хряща | |
| RU2017489C1 (ru) | Лекарственное средство для парентерального питания и дезинтоксикации | |
| JPWO2022251624A5 (enExample) | ||
| FI3989999T3 (fi) | Haaraketjuisia aminohappoja käsittävä uusi koostumus | |
| KR960000068B1 (ko) | 영양소 조성물의 제조방법 |